Skip to content
InMed-logo-01
  • Pharmaceutical
    • INM-901 for Alzheimer’s Disease
    • INM-089 for Age-related Macular Degeneration
    • INM-755 for Epidermolysis Bullosa
  • Investors
    • News Releases
    • Events
    • Stock Information
    • Corporate Governance
    • Financials & AGM Materials
    • Filings
    • Presentations
    • Media and Videos
    • Investor Contact
  • Corporate
    • Management
    • Board of Directors
    • Scientific Advisors
    • Partners and Collaborators
    • Careers
    • Contact
  • Learn
  • Pharmaceutical
    • INM-901 for Alzheimer’s Disease
    • INM-089 for Age-related Macular Degeneration
    • INM-755 for Epidermolysis Bullosa
  • Investors
    • News Releases
    • Events
    • Stock Information
    • Corporate Governance
    • Financials & AGM Materials
    • Filings
    • Presentations
    • Media and Videos
    • Investor Contact
  • Corporate
    • Management
    • Board of Directors
    • Scientific Advisors
    • Partners and Collaborators
    • Careers
    • Contact
  • Learn

Filings

Form TypeForm DescriptionFiling DateReport DateView Report
DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) material2024-10-28
8-KCurrent report2024-10-282024-10-28
DEF 14AOther definitive proxy statements2024-10-282024-12-18
8-KCurrent report2024-10-242024-10-24
8-KCurrent report2024-10-232024-10-22
424B3Prospectus [Rule 424(b)(3)]2024-10-17
8-KCurrent report2024-09-302024-09-30
10-KAnnual report [Section 13 and 15(d), not S-K Item 405]2024-09-302024-06-30
8-KCurrent report2024-09-262024-09-26
8-KCurrent report2024-09-202024-09-17
8-KCurrent report2024-08-212024-08-21
8-KCurrent report2024-08-202024-08-20
4Statement of changes in beneficial ownership of securities2024-08-022024-07-31
8-KCurrent report2024-07-302024-07-30
8-KCurrent report2024-06-282024-06-27
424B3Prospectus [Rule 424(b)(3)]2024-06-28
8-KCurrent report2024-06-282024-06-27
8-KCurrent report2024-06-112024-06-10
4Statement of changes in beneficial ownership of securities2024-05-282024-05-27
4Statement of changes in beneficial ownership of securities2024-05-282024-05-27
8-KCurrent report2024-05-142024-05-14
10-QQuarterly report [Sections 13 or 15(d)]2024-05-142024-03-31
8-KCurrent report2024-04-182024-04-18
8-KCurrent report2024-04-162024-04-16
8-KCurrent report2024-04-052024-04-04
8-KCurrent report2024-03-202024-03-19
4Statement of changes in beneficial ownership of securities2024-03-052024-03-04
4Statement of changes in beneficial ownership of securities2024-03-052024-01-14
4Statement of changes in beneficial ownership of securities2024-03-052024-01-21
3Initial statement of beneficial ownership of securities2024-02-272024-02-20
  • « Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 16
  • Next »

Investor Alerts

Sign up for investor alerts!
Sign Up

Information Request

Send us a request for information
Learn More
InMed-logo-mono

#1445 – 885 West Georgia St.
Vancouver, BC, Canada
V6C 3E8

Pharmaceutical

  • INM-901 for Alzheimer’s Disease
  • INM-089 for Age-related Macular Degeneration
  • INM-755 for Epidermolysis Bullosa

Investor

  • News
  • Events
  • Stock Information
  • Corporate Governance
  • Financials & AGM Materials
  • Filings
  • Presentations
  • Media & Videos
  • Investor Contact

CORPORATE

  • Management
  • Board of Directors
  • Scientific Advisors
  • Partners and Collaborators
  • Careers
  • Contact

Learn

  • Articles and Videos
  • Webinar: Alzheimer’s Outlook – Neuroinflammation, the Next Step
  • The Evolving Alzheimer’s Disease Landscape

© Copyright 2026 InMed Pharmaceuticals Inc.

  • Privacy Policy
  • Terms of Use
  • Legal Disclaimer
  • Find Us On:
Subscribe

Sign up to receive emails from InMed Pharmaceuticals

"*" indicates required fields

Name*
Consent*